Literature DB >> 8096788

Glutamate metabotropic receptor mediated depression of synaptic inputs to lamprey reticulospinal neurones.

S Alford1, R Dubuc.   

Abstract

The transmission of vestibular inputs to reticulospinal (RS) neurones of the posterior rhombencephalic nucleus (PRRN) has been shown to be depressed by the bath application of N-methyl-D-aspartate (NMDA). The aim of this study was to investigate the pharmacological mechanism involved using patch clamp recordings of reticulospinal neurones. It is demonstrated that the chemical component of vestibular inputs to the PRRN is mediated by glutamatergic synapses utilising alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors on the PRRN neurones. Monosynaptic excitatory postsynaptic currents (EPSCs) from octavomotorius relay cells to RS neurones are markedly depressed by the application of NMDA, a depression which was insensitive to competitive and non-competitive NMDA receptor antagonists. The effect of NMDA was eliminated by inactivation of G proteins. A similar depressive effect was observed following application of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) to the superfusate. It is concluded that NMDA acts at a metabotropic receptor located most likely presynaptically to reticulospinal neurones on terminals of octavomotorius relay cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096788     DOI: 10.1016/0006-8993(93)91370-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  NMDA receptor-mediated control of presynaptic calcium and neurotransmitter release.

Authors:  A J Cochilla; S Alford
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

2.  Muscarinic receptor activation elicits sustained, recurring depolarizations in reticulospinal neurons.

Authors:  R W Smetana; S Alford; R Dubuc
Journal:  J Neurophysiol       Date:  2007-03-07       Impact factor: 2.714

3.  Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction.

Authors:  Steve Zaldua; Frederick C Damen; Rohan Pisharody; Riya Thomas; Kelly D Fan; Giri K Ekkurthi; Sarah B Scheinman; Sami Alahmadi; Felecia M Marottoli; Simon Alford; Kejia Cai; Leon M Tai
Journal:  Heliyon       Date:  2020-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.